Supreme Court Closes Contempt Case Against Patanjali Over Misleading Ads

In a significant culmination to a months-long legal battle, the Supreme Court of India has closed contempt proceedings against Patanjali Ayurved and its founders, Baba Ramdev and Acharya Balkrishna. The decision follows the publication of unconditional public apologies by the company for breaching a solemn undertaking given to the Court regarding misleading advertisements.

---

Introduction: A Contempt Saga Concludes

The Supreme Court bench, comprising Justices Hima Kohli and Ahsanuddin Amanullah, brought an end to the high-profile contempt of court case initiated against Patanjali Ayurved. The case, which captured national attention, stemmed from the company's violation of an assurance made to the Court in November 2023. Patanjali had pledged to cease all electronic and print advertisements containing misleading claims about its products' efficacy, particularly those disparaging modern medicine (allopathy).

The Court's decision to accept the apologies and close the proceedings marks a pivotal moment in the discourse on corporate accountability, advertising ethics, and the sanctity of judicial undertakings. While discharging the contemnors, the bench issued a stern caution, making it clear that they are not being let "off the hook" entirely and must remain vigilant and compliant with the law.

Case Background: A Breach of Solemn Undertaking

The legal dispute originated from a petition filed by the Indian Medical Association (IMA), which accused Patanjali of conducting a smear campaign against modern medicine and making unsubstantiated claims about curing diseases, in direct violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

On November 21, 2023, Patanjali Ayurved, through its counsel, gave a "solemn undertaking" to the Supreme Court. The company promised to refrain from making any causal statements in print or electronic media about its products or their medicinal efficacy. Furthermore, they assured the Court that there would be no advertisements disparaging any system of medicine, including allopathy.

However, just a day after this undertaking, Baba Ramdev and Acharya Balkrishna held a press conference. Subsequently, Patanjali continued to publish advertisements that the Court found to be in direct contravention of its order. This defiance prompted the Supreme Court to issue contempt notices in February 2024, demanding to know why action should not be taken against the company and its founders.

Judicial Scrutiny and Unconditional Apologies

The ensuing hearings were marked by sharp rebukes from the bench. The Court repeatedly expressed its displeasure with the contemnors' initial, half-hearted apologies, which it deemed "lip service." The bench criticized the casual nature of their affidavits and their failure to grasp the gravity of defying a Supreme Court order.

This judicial pressure led to a series of escalating apologies. Initially, the apologies were qualified and submitted only in affidavits. The Court found these inadequate and insisted on a public demonstration of remorse. Consequently, Patanjali published multiple, prominent apologies in major national newspapers. These public statements expressed "unconditional and unqualified" regret for their actions and reaffirmed their respect for the rule of law and the dignity of the judiciary.

In court, Senior Advocate Mukul Rohatgi, representing the founders, emphasized that his clients had published the apologies "from their heart" and had already taken down the offending advertisements. He reiterated their commitment to abide by the law going forward.

The Court's Rationale for Closure

In its final order, the bench acknowledged the contemnors' efforts to atone for their breach. Justice Kohli and Justice Amanullah noted the prominence and widespread publication of the public apologies. While closing the case, the Court underscored the importance of the message sent to the public and the corporate world. The ruling serves as a powerful reminder that undertakings given to the highest court of the land cannot be treated lightly.

The bench's decision was not a full exoneration. It was a conditional acceptance of the apology, coupled with a stern warning. "We have considered the subsequent apologies and undertakings. We are of the opinion that they should be adhered to," the bench stated, placing the onus squarely on Patanjali to maintain future compliance.

Broader Legal and Regulatory Implications

This case has significant ramifications for legal practitioners in several domains:

1. Advertising and Consumer Law: The proceedings have brought the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, into sharp focus. The Court's actions signal a lower tolerance for advertisements that make magical or unsubstantiated therapeutic claims. Legal advisors for FMCG and pharmaceutical companies will need to exercise greater caution in vetting advertising copy to ensure compliance.

2. Contempt of Court Jurisprudence: The case provides a modern-day example of how the judiciary wields its contempt powers to enforce its orders against powerful corporate entities. The Court's insistence on a public, not just a written, apology sets a high bar for what constitutes genuine remorse in corporate contempt cases. It demonstrates that the Court is willing to look beyond legal filings to the real-world conduct of the contemnors.

3. Corporate Governance and Accountability: The saga highlights the personal liability of company directors and promoters for corporate actions. The summoning of Baba Ramdev and Acharya Balkrishna in person underscores the principle that the corporate veil will not protect individuals who are directly responsible for defying court orders.

4. The Allopathy vs. Ayurveda Debate: While the case was procedurally about contempt, its substance touched upon the long-standing tensions between traditional and modern medicine. The Court's actions were aimed not at invalidating Ayurveda but at regulating the public claims made by its practitioners, ensuring they are not presented in a manner that unlawfully denigrates other medical systems or misleads vulnerable consumers.

Conclusion: A Cautionary Tale

The closing of the Patanjali contempt case is not merely the end of a legal chapter; it is a cautionary tale for the entire corporate sector. The Supreme Court has demonstrated both its power to demand accountability and its capacity for judicial grace when genuine contrition is shown. For legal professionals, the case serves as a critical study on the intersection of advertising law, constitutional powers, and the profound importance of honoring commitments made before a court of law. While Patanjali and its founders have been discharged from the contempt notice, they remain under the watchful eye of the judiciary and the public, bound by their renewed, and now very public, undertaking.